C. Hegedüs

发表

Antibody binding shift assay for rapid screening of drug interactions with the human ABCG2 multidrug transporter.

G. Várady, Z. Takáts, B. Sorrentino, 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Regulation of the Function of the Human ABCG2 Multidrug Transporter by Cholesterol and Bile Acids: Effects of Mutations in Potential Substrate and Steroid Binding Sites

B. Sarkadi, A. Váradi, C. Özvegy‐Laczka, 2014, Drug Metabolism and Disposition.

Major Clinical Response to Afatinib Monotherapy in Lung Adenocarcinoma Harboring EGFR Exon 20 Insertion Mutation.

L. Urban, C. Hegedüs, R. Dóczi, 2020, Clinical lung cancer.

on Transporters in Toxicity and Disease Regulation of the Function of the Human ABCG 2 Multidrug Transporter by Cholesterol and Bile Acids : Effects of Mutations in Potential Substrate and Steroid Binding Sites s

B. Sarkadi, A. Váradi, C. Özvegy‐Laczka, 2014 .

Interaction of the EGFR inhibitors gefitinib, vandetanib, pelitinib and neratinib with the ABCG2 multidrug transporter: implications for the emergence and reversal of cancer drug resistance.

G. Szakács, J. Settleman, G. Kéri, 2012, Biochemical pharmacology.

PI3-kinase and mTOR inhibitors differently modulate the function of the ABCG2 multidrug transporter.

G. Antalffy, B. Sarkadi, A. Váradi, 2012, Biochemical and biophysical research communications.

Mutations of the central tyrosines of putative cholesterol recognition amino acid consensus (CRAC) sequences modify folding, activity, and sterol-sensing of the human ABCG2 multidrug transporter.

G. Szakács, B. Sarkadi, A. Váradi, 2015, Biochimica et biophysica acta.

The Role of ABC Multidrug Transporters in Resistance to Targeted Anticancer Kinase Inhibitors

B. Sarkadi, T. Hegedűs, C. Hegedüs, 2015 .

Molecularly-targeted anti-cancer drug interactions of the human ABCG2 multidrug transporter

C. Hegedüs, 2013 .

Lipid regulation of the ABCB1 and ABCG2 multidrug transporters.

B. Sarkadi, T. Hegedűs, C. Özvegy‐Laczka, 2015, Advances in cancer research.

Tyrosine kinase inhibitors as modulators of ATP binding cassette multidrug transporters: substrates, chemosensitizers or inducers of acquired multidrug resistance?

G. Szakács, B. Sarkadi, T. Hegedűs, 2011, Expert opinion on drug metabolism & toxicology.

Application of fluorescent dye substrates for functional characterization of ABC multidrug transporters at a single cell level

G. Várady, B. Sarkadi, Á. Telbisz, 2016, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Aerosol deposition modeling in human airways and alveoli

S. Török, W. Hofmann, C. Hegedüs, 2000 .

Chemotherapeutic sensitivity of human colorectal tumor xenografts.

C. Hegedüs, K. Lapis, L. Kopper, 1980, Oncology.

Reduction of Bcr‐Abl Function Leads to Erythroid Differentiation of K562 Cells via Downregulation of ERK

K. Német, C. Hegedüs, M. Magócsi, 2006, Annals of the New York Academy of Sciences.

Regulation of the Function of the Human ABCG2 Multidrug Transporter by Cholesterol and Bile Acids: Effects of Mutations in Potential Substrate and Steroid Binding Sites

B. Sarkadi, A. Váradi, C. Özvegy‐Laczka, 2014, Drug Metabolism and Disposition.